What BPS Bioscience Inc. does

BPS Bioscience Inc. is a privately held San Diego-based biotechnology company founded in 2005 that manufactures bioactive recombinant proteins, biochemical assay kits, stable cell lines, virus-based tools (lentivirus, AAV, VSV), virus-like particles (VLPs), antibodies, and small-molecule inhibitors/activators for drug discovery research. Its proprietary HiP™ protein platform delivers high-purity (>90%) and low-aggregation (<10%) reagents, and the company also develops unique screening tools such as the PARPTrap™ Combo Assay and WRN Helicase Activity Assay. The portfolio spans over 4,500 SKUs across 2,000+ proteins, 250+ stable cell lines, 700+ screening assays, and emerging cell-therapy consumables (TCellM medium, NK Cell Expansion Kit), supported by an ISO 9001:2015-certified quality system and cited in 4,000+ peer-reviewed publications since 2010.

The company monetizes through one-time catalog sales (quote-based pricing with new-customer discounts of 10–50%), contract screening and profiling services run against its 700+ assay library, custom development projects spanning proteins, cell lines, viral vectors, bispecifics, CRISPR tools, and PROTACs, and newly introduced recurring revenue instruments including an annual Cell Line Subscription program with optional on-site banking and a 3-month Cell Line Rental program. Go-to-market combines direct US sales (web, phone, fax, dedicated reps for bulk orders), a worldwide distributor network, and a self-service e-commerce platform with Quick Order and Advanced Search across 1,000+ targets, targeting pharmaceutical and biotechnology companies, academic and research institutions, and cell and gene therapy developers.

Operationally, the company employs 51–100 staff at its San Diego headquarters, which houses R&D, manufacturing, and cell line banking. Distribution relies on direct sales for US enterprise accounts and an international distributor network, with localized Chinese and Japanese storefronts and active content marketing (newsletters, webinars, YouTube, scientific conferences) supporting customer acquisition. The founder, Henry Zhu, serves as President and CEO.

Name

BPS Bioscience Inc.

Legal name

BPS Bioscience, Inc.

Website

https://bpsbioscience.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

BPS Bioscience is a San Diego-based private biotech that manufactures over 4,500 recombinant proteins, assay kits, cell lines, virus-based tools, and VLPs for drug discovery researchers in pharmaceutical, biotechnology, and academic institutions worldwide.

Ownership category

akta.pro rank

Product category

Biotechnology Research Reagents

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Cell-Based & Potency Assays (Bioassays) (HLAGADAH), High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

Keywords

• Recombinant protein manufacturing
• Biochemical assay kits
• Stable cell line development
• Viral vector tools
• Drug discovery reagents

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Research Products Sales: Sale of recombinant proteins, assay kits, cell lines, antibodies, inhibitors/activators, and virus-based tools (AAV, lentivirus, VSV) to pharmaceutical companies, biotech firms, and academic researchers. Products are sold as catalog items with standard pricing.
2. Screening & Profiling Services: Contract research services screening compounds against their library of 700+ assays, providing dose-response profiles across enzyme families, and cell-based screening services.
3. Custom Development Services: Bespoke product development including custom proteins, assay kits, viruses, cell lines, iPSC-derived cells, CAR-T development, CRISPR services, and PROTAC development. Projects are customized to researcher specifications.
4. Cell Line Subscriptions: Annual subscription program allowing purchase of cell lines with additional vials at reduced cost, plus optional cell banking at BPS facility with shipment upon request during the subscription period.
5. Cell Line Rental Program: Three-month rental program for cell lines at 50% of purchase cost, providing access without full ownership commitment.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

BPS Bioscience manufactures and sells bioactive recombinant proteins, biochemical and cell-based assay kits, stable reporter cell lines and iPSC-derived cells, virus-based tools (lentivirus, AAV, VSV, VLPs), antibodies, and small-molecule inhibitors/activators for drug discovery research. It complements this catalog with contract screening and profiling services run against 700+ assays and custom development services spanning proteins, cell lines, viral vectors, bispecific antibodies, CAR-T tools, CRISPR, and PROTACs.

Product overview

BPS Bioscience Inc. is a biotech reagent and assay kit manufacturer offering over 4,500 products for drug discovery research. The portfolio centers on bioactive proteins (including HiP high-purity/low-aggregation proteins), biochemical assay kits (in AlphaLISA, chemiluminescent, colorimetric, fluorogenic, TR-FRET formats), virus-like particles (VLPs), and cell systems (250+ stable cell lines, iPSC-derived cells, primary cells, and media). Virus-based tools span lentiviruses, AAV, and VSV for gene transfer and viral infection modeling. Complementary products include cell-based assays, antibodies, and inhibitors/activators. Services encompass screening against 700+ assays, custom development (proteins, cell lines, viral vectors, bispecifics, CRISPR, PROTACs), and instrument-specific luciferase reagents (ONE-Step, TWO-Step, LIVE-Step systems, In Vivo-Luc). The company operates an ISO 9001:2015-certified quality system and maintains R&D and manufacturing in San Diego, CA.

Differentiator

Problem solved

Functional benefit

Brands

• HiP™ (High-Purity) Proteins: High-purity, low-aggregation recombinant protein products optimal for generating clear and consistent research data.
• ONE-Step™ Luciferase Assay System
• TWO-Step Luciferase Assay System
• LIVE-Step™ Cell Assay System
• In Vivo-Luc™ Imaging Solution
• TCellM™
• NK Cell Expansion Kit

Products and services

• Recombinant Proteins High-purity, bioactive recombinant enzymes and proteins (including epigenetic and metabolic enzymes, kinases, cancer-related proteins and mutants, and immune checkpoint molecules) with the HiP™ high-purity/low-aggregation product line, sold to drug discovery researchers in pharma, biotech, and academia.
• Biochemical Assay Kits Validated biochemical assay kits for screening inhibitors of drug discovery targets, offered in multiple formats including AlphaLISA, chemiluminescent, colorimetric, fluorogenic, fluorescence polarization, TR-FRET, and UV spectrophotometric.
• Cell Lines, iPSCs & Primary Cells More than 250 stable engineered cell lines (reporter, overexpressing, knockout), iPSC-derived cells, and primary cells for immunotherapy, CAR-T therapy, cell signaling, metabolism, and neuroscience research.
• Cell Media & Luciferase Reagents Ready-to-use cell culture media and luciferase assay systems, including ONE-Step™ Luciferase Assay System, TWO-Step Luciferase (Firefly & Renilla) Assay System, LIVE-Step™ Cell Assay System, and specialized media for T cell and NK cell research.
• Virus-Based Tools Lentiviruses, AAV (Adeno-Associated Viruses), and VSV (Vesicular Stomatitis Virus) tools for genetic engineering, viral infection modeling, and gene therapy research, including CAR-T constructs, CRISPR tools, and spike-pseudotyped viruses for coronavirus research.
• Cell-Based Assays & Expression Kits Cell-based assay kits for confirming biochemical findings in cellular context, including cell signaling pathway kits, immunotherapy assays, and phosphodiesterase cell-based assays.
• Antibodies Research antibodies including antibody-drug conjugates (ADCs), FluoSite fluorescent-labeled antibodies for flow cytometry, bispecific and trispecific antibodies, CAR-T cell therapy antibodies, epitope tags, and neutralizing antibodies.
• Inhibitors / Activators Small molecule inhibitors and activators targeting acetyltransferases, apoptosis, bromodomains, deacetylases, demethylases, heat shock proteins, kinases, methyltransferases, PARPs, phosphodiesterases, proteases, and ubiquitination pathways.
• Virus-Like Particles (VLPs) Platform for native display of transmembrane proteins in their functional conformation using HEK293 mammalian expression systems, used for antibody discovery and immunization with targets including GPRC5D, Claudin-6, and CD20.
• Cell Isolation Kits Kits for cell isolation and separation workflows supporting cell biology research.
• Screening & Profiling Services Contract research service offering biochemical and cell-based screening against 700+ assays for compound identification and dose-response profiling across enzyme families including kinases, PARPs, proteases, and immunotherapy targets.
• Custom Development Services Custom product development including protein production and labeling, stable cell line development, custom cell-based assay development, CAR-T cell development, custom lentivirus and AAV services, bispecific antibody development, CRISPR services, PROTAC development, and BLI protein binding studies.
• TCellM™ Cell Culture Medium Ready-to-use specialized medium for primary T cell culture and CAR-T cell research, available in serum-free formulation for enhanced consistency.
• NK Cell Expansion Kit Complete kit including engineered K562 feeder cells, NK Cell Basal Medium, and recombinant human IL-2 for NK cell expansion.
• LIVE-Step™ Cell Assay System Real-time cell viability analysis system providing homogeneous, sensitive luminescence quantification of metabolically active viable mammalian cells with signal stability over 5 hours.
• In Vivo-Luc™ Imaging Solution Ready-to-use, sterilized, endotoxin-free D-Luciferin solution for in vivo bioluminescence imaging of firefly luciferase expression in animal models.
• Cell Line Rental Program Three-month rental program for cell lines at 50% of purchase cost, providing access to cell lines without full ownership commitment.
• Cell Line Subscription Program Annual subscription allowing purchase of cell lines with 10 or 20 additional vials at reduced cost from the same lot, plus optional cell banking at BPS facility and shipment upon request during the subscription period.

Quantifiable outcome

• Over 4,000 academic citations since 2010
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Worldwide DistributorscoreChannel Partner/ Reseller/ DistributorBPS Bioscience maintains a network of worldwide distributors to serve international customers outside the United States. These distributors enable global reach for the company's research products and services.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Promega Corporation: Promega is a privately held life science tools company offering assay kits, reporter technologies, and enzymes. Its luciferase assay systems and cell-based assay kits compete directly with BPS's ONE-Step/TWO-Step/LIVE-Step luciferase and cell-based assay product lines.
• Abcam: Abcam (now part of Danaher) is a major research antibody and reagent supplier with extensive catalog depth and global reach. It is comparable to BPS across its antibody portfolio and adjacent recombinant protein offerings, though Abcam operates at substantially greater scale and geographic breadth.
• Bio-Techne: Bio-Techne (NASDAQ: TECH), owner of R&D Systems and Tocris Bioscience, is a major life science reagents and tools company. It directly overlaps BPS across recombinant proteins, assay kits, and small molecule inhibitors and is substantially larger in scale, catalog breadth, and global reach.

Direct peers

• Enzo Life Sciences: Enzo Life Sciences manufactures biochemical and cellular assay kits, recombinant proteins, antibodies, and small molecules. It competes with BPS across assay kits, proteins, and inhibitor/activator product lines serving pharma, biotech, and academic drug discovery customers.
• Cell Signaling Technology: CST is a privately held provider of antibodies, recombinant proteins, and assay kits focused on cell signaling research. It is comparable to BPS in its scientist-driven culture, citation footprint, and product breadth across signaling proteins, antibodies, and ELISA/assay kits.
• GenScript: GenScript provides gene synthesis, recombinant proteins, antibodies, and cell line engineering services. It is comparable to BPS across recombinant protein production, antibody offerings, custom cell line development, and gene synthesis/CAR-T services for drug discovery customers.
• Active Motif: Active Motif specializes in epigenetics-related research tools, including recombinant proteins, antibodies, and assay kits for chromatin biology. It overlaps with BPS's strong epigenetics enzyme portfolio (acetyltransferases, deacetylases, methyltransferases, bromodomains) and serves similar academic and pharma customers.
• Cayman Chemical: Cayman Chemical manufactures biochemical reagents, assay kits, antibodies, and small molecule inhibitors used in life science research. It overlaps BPS directly across biochemical assays, inhibitors/activators, and recombinant proteins, with similar mid-sized reagent company positioning and academic/biotech customer base.
• Boster Bio: Boster Bio is a privately held antibody and ELISA kit manufacturer serving academic and pharma research markets. It overlaps BPS across antibodies, ELISA/assay kits, and recombinant proteins with a similar catalog breadth and customer base profile.

Emerging players

• Eurofins Discovery: Eurofins Discovery offers contract research services including compound screening, ADME, and bioanalytical assays. It is comparable to BPS's screening and profiling services arm (700+ assays) and competes for outsourced drug discovery screening budgets from pharma and biotech sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bpsbioscience
• YouTubeyoutube.com/channel/UChthvBVFrcFyLb_OHy7D7EQ
• Facebookfacebook.com/bpsbioscience
• LinkedInlinkedin.com/company/bps-bioscience-inc
• Instagraminstagram.com/bpsbioscience

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BPS Bioscience Inc.